Article
BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trial
2024-05-04
Abstract excerpt
<h4>ABSTRACT</h4> <h4>BACKGROUND</h4> Genetic testing to identify germline high-risk pathogenic variants in breast cancer susceptibility genes is an important step in the breast cancer diagnostic pathway. To expand capacity and reduce turnaround time, testing is increasingly offered within ‘mainstream’ oncology services, rather than via referral to clinical genetics. However, mainstream capacity is also stretched,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bdde3b0c-d770-51db-b8f1-cf8aaf16e56d
- DOI
- 10.1101/2024.05.03.24306669
